3 injections—up to 6 months of pain relief2-5

What can I expect during treatment with EUFLEXXA?

Getting started

Since treatment with EUFLEXXA consists of 3 injections for 3 consecutive weeks (1 course), scheduling each appointment with your doctor is a great place to start.2

Keep track of your appointments by:

Setting reminders on your cell phone

Writing each appointment on your calendar

Scheduling appointments on the same day of the week

Remember, going to each appointment is key
to maximizing your
OA knee pain relief

During treatment

Pain relief can begin as early as a week after your first injection and continues to improve after each injection for up to 6 months.2,5

Clinical studies have shown that getting all 3 injections of
EUFLEXXA improves the pain relief you may experience2,5

What should I do after each treatment with EUFLEXXA?

After each injection

It’s important to follow these 3 steps2:

  1. Avoid physical activity for 48 hours, including standing for more than 1 hour at a time

  2. Ice your knee if you have any mild pain or swelling
    If you experience joint pain, back pain, limb/muscle pain, joint swelling, or any other problems, call your doctor right away

  3. Ask your doctor when you can begin major physical activities again

After each course

Stay ahead of the pain. Make sure you follow up with your doctor 6 months after your third injection to schedule another course of EUFLEXXA.

Repeat treatment with EUFLEXXA was well-tolerated for an additional 6 months2-4

Watch one patient’s experience with EUFLEXXA

Watch one patient’s experience with EUFLEXXA

See Jan’s Full Story

I began experiencing relief from pain about 6-8 weeks after injection [1 round of EUFLEXXA], until all of a sudden I realized I had no pain in my knee.”

– Jan, a real EUFLEXXA patient

Individual results may vary.

About EUFLEXXA

Find out how EUFLEXXA stands apart.

See the Difference

Proven Results

Discover the clinical study results EUFLEXXA had in patients with OA knee pain.

Explore the Results
  1. Rolling 12 month average of IQVIA claims data based on unique patients (December 2022).
  2. EUFLEXXA [package insert]. Parsippany, NJ: Ferring Pharmaceuticals Inc.
  3. Altman RD, Rosen JE, Bloch DA, et al. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX Trial). Semin Arthritis Rheum. 2009;39(1):1-9.
  4. Altman RD, Rosen JE, Bloch DA, et al. Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial. Osteoarthritis Cartilage. 2011;19(10):1169-1175.
  5. Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2006;14(2):154-162.

Please see Important Safety Information and Full Prescribing Information

Indication

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used for patients who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

EUFLEXXA is only for injection into the knee, performed by a doctor or other qualified healthcare professional.

Important Safety Information

  • Do not take this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products.
  • You should not have EUFLEXXA injected into the knee if you have a knee joint infection or skin diseases or infections around the injection site.
  • EUFLEXXA has not been tested in pregnant women, women who are nursing or in children less than 18 years of age. After you receive your EUFLEXXA injection you should avoid physical activities for 48 hours such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour at a time.)
  • The most common adverse events related to EUFLEXXA injections were joint pain, back pain, limb pain, muscle pain, and joint swelling.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

You may also contact Ferring Pharmaceuticals Inc. at 1-888-FERRING.

Indication

EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used for patients who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

EUFLEXXA is only for injection into the knee, performed by a doctor or other qualified healthcare professional.

Important Safety Information

  • Do not take this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products.
  • You should not have EUFLEXXA injected into the knee if you have a knee joint infection or skin diseases or infections around the injection site.
  • EUFLEXXA has not been tested in pregnant women, women who are nursing or in children less than 18 years of age. After you receive your EUFLEXXA injection you should avoid physical activities for 48 hours such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour at a time.)
  • The most common adverse events related to EUFLEXXA injections were joint pain, back pain, limb pain, muscle pain, and joint swelling.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

You may also contact Ferring Pharmaceuticals Inc. at 1-888-FERRING.

©2024 Ferring B.V. All rights reserved.
US-EU-2300041

The content on this website is for informational purposes only and is not intended to replace a discussion with a healthcare professional.

Get a head start: Check your coverage and sign up for your EUFLEXXA coverage certificate

Check your coverage below to see if you may be covered through your insurance provider for EUFLEXXA

EUFLEXXA is covered on Medicare Part B*, and is covered by most private plans. Your healthcare provider’s office will check your benefits.

Your EUFLEXXA coverage certificate will let you know if you are covered. Bring your certificate to your doctor to discuss EUFLEXXA as a possible treatment option for you.

MM slash DD slash YYYY
Address(Required)

By signing up, I am giving Ferring Pharmaceuticals Inc. (“Ferring”) permission to store and use the information that I have provided. I understand and agree that my information will be used by Ferring (or companies working on Ferring’s behalf) to contact me by telephone, email, or mail to provide me with information about products or services that may be of interest to me. I understand that my information will be treated as described in Ferring’s Privacy Notice, which provides details about my privacy rights. Also, I understand that I may opt out of the database at any time by making the request at Data Subject Form, or by calling 1-888-FERRING, Monday through Friday, 8 AM to 7 PM ET to speak to a representative or leave a voicemail. This statement may be updated from time to time.

This program assists in the determination of whether treatment could be covered by the applicable third-party payer based on coverage guidelines provided by the payer and patient information provided by you. Third-party reimbursement is affected by many factors. Therefore, we make no representation or guarantee that full or partial insurance reimbursement or any other payment will be available. This is not intended to be medical advice. Please consult with your healthcare provider to determine which treatment may be right for you.

*Out-of-pocket cost may apply. Please check with your doctor.

This website may contain links to, or be accessed from links on, other worldwide websites. Ferring does not have responsibility for or control the contents, availability, operation or performance of other websites to which this website may be linked or from which this website may be accessed.

Ferring makes no representation regarding the content of any other websites which you may access from this website.

Ok Cancel